EU AI Act bars biometric workplace emotion inference except for medical or safety uses

Define the function before classifying the product

Start with the data and claimed inference. Article 3(39) ties emotion recognition to biometric data used to identify or infer emotions or intentions. Record the exact signal, asserted output, affected person, workplace context, intended purpose, decision influence, provider, configuration, and owner. Do not silently treat every sentiment label, self-report, physical-state alert, or detection of a visible expression as the same statutory function; preserve the facts and route classification to qualified review.

Keep the exception tied to intended medical or safety use

Article 5(1)(f)'s exception turns on a use intended for medical or safety reasons, not a broad product category or an untested vendor label. Record the intended purpose in design, configuration, and contract records; identify who determines it, how the output is used, and whether the same feature also influences hiring, performance, discipline, or access to work. Mixed purposes, secondary use, territorial scope, and the evidence supporting the exception require qualified review.

Stop affected employment paths while facts are reviewed

When a feature appears to infer emotion from biometric data in a workplace and an intended medical or safety use has not been established, isolate the feature, preserve its configuration and use record, and prevent the output from affecting an applicant or worker while qualified reviewers assess the facts. A human glance at the output does not by itself resolve Article 5 because the provision addresses placing on the market, putting into service for the prohibited purpose, and use.

Make disabling and change control testable

Contracts and configuration records should identify optional emotion-related features, defaults, biometric inputs, model or service dependencies, derived fields, exports, retention, deletion, and change notifications. Test that disabling the feature stops the relevant collection and inference across employee interfaces, administrator views, APIs, integrations, reports, and historical reprocessing. Preserve the Regulation, provider representation, observed configuration, exception analysis, decision owner, and review date as separate records so a renamed feature or product update cannot silently change the assessed use.

Turn this source into a reviewable decision

For AI for CHROs, use this briefing as a dated decision record rather than a substitute for the source. Preserve Official Journal of the European Union, the exact URL, the July 25, 2026 review date, the supported facts above, the editorial interpretation, the limitations, and any buyer-specific evidence. Link that record to the decisions most directly affected: Recruiting and candidate support; Performance and work allocation; People analytics and employee listening; Workplace AI governance and change. State whether the source changes the scope, evidence requirement, control, sequence, or only the language used to describe the decision.

Before action, name the accountable owner, affected population and workflow, exact offering or configuration, source data and rights, human decision point, exception and appeal path, complete cost, expected benefit, failure and stop conditions, retained evidence, and next review date. Keep official facts, provider statements, buyer observations, representative tests, measured outcomes, editorial inferences, and unknowns visibly separate. Reopen the record when the source, offer, model, integration, data, policy, population, responsible person, or measured result changes.

Limitations and unknowns

The Regulation establishes the biometric-data definition, Article 5(1)(f) prohibition and medical-or-safety exception, and staged application dates. It does not classify a particular product, determine whether a signal is biometric, establish an intended use, resolve territorial or role applicability, or replace qualified employment, privacy, or legal review.